Landmark Bio signs manufacturing agreement with Galapagos
Under the agreement, Landmark Bio will be responsible for performing Good Manufacturing Practice (GMP) manufacturing of clinical trial…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Nov 23
Under the agreement, Landmark Bio will be responsible for performing Good Manufacturing Practice (GMP) manufacturing of clinical trial…
07 Nov 23
Genevant’s collaboration with Novo Nordisk builds upon a joint research and development collaboration in hemophilia A between Novo…
07 Nov 23
The Transaction remains subject to the sanction of the Scheme by the High Court of Justice of England…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Nov 23
Under the terms of the expanded partnership, the French drugmaker will extend its licencing rights to Ebvallo in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Nov 23
As per the terms of the agreement, Lupin will have semi-exclusive rights to co-market the product in India…
06 Nov 23
The results showed statistically significant and clinically meaningful reductions in UACR, used to assess albuminuria, at 12 weeks…
06 Nov 23
The results were consistent across every month and every-other-month dosing of Izervay against sham through two years of…
06 Nov 23
PM8002 is currently undergoing Phase 2 studies in China to assess its efficacy and safety as a monotherapy…
03 Nov 23
The extended collaboration with the Broad Institute of MIT and Harvard, which aims to identify cancer targets and…
03 Nov 23
The approved Type II Variation application pertains to the use of Ryeqo in women who have a history…